Supplement: Effects of Comorbidity Management and Complex Care Coordination on Cancer Caregivers

项目总结。这份多样性副刊的首要目标是准备和推出Dr.Maria 莉莎特·兰赫尔作为一名独立科学家进入了学术生涯。兰赫尔博士是一位行为科学家， 博士后研究与致力于治疗医疗服务不足的癌症有关 患者、家庭和社区。通过这一多样化补充，她将获得至关重要的癌症培训 专注于癌症护理的对照研究，癌症期间/之后共病管理的挑战- 定向治疗，先进的统计分析。着眼于开发干预措施以支持 护理人员在整个癌症控制过程中管理患者合并症的具体目标 补充研究是为了：1)检查患者对父母的参与是否优化(肿瘤学- 初级保健伙伴关系改善综合生存护理)共病的强化护理途径 管理改善了照顾者的结局，降低了照顾者的负担，痛苦， 以及相对于常规医疗(UMC)的经济困难；2)描述照顾者在 在癌症导向治疗期间管理患者的合并症；以及，3)描述 当患者从癌症指导治疗过渡到治疗后存活时，照顾者会经历。 兰赫尔博士将通过招募符合条件并登记参加 父母优化试验，并使用照顾者访谈和调查进行混合方法的同伴研究 数据。作为研究计划的补充，职业发展目标包括1)获得基础 了解癌症控制健康公平研究，2)发展理论和概念知识 癌症护理研究，3)继续发展方法和分析定性，定量， 以及进行严格的混合方法研究所需的混合方法技能，以及4)获得专业知识 发展技能，以支持独立调查员的职业生涯。以及宝贵的培训和 通过本附录提供的职业发展机会，兰赫尔博士支持的研究结果 研究将提供有关癌症护理人员未得到满足的需求的关键数据，并使她能够制定 竞争的K99/R00提案，为患有癌症和癌症的患者的照顾者开发干预措施 开始她作为一名独立调查员的职业生涯。

PROJECT SUMMARY. The overarching goal of this Diversity Supplement is to prepare and launch Dr. Maria Lizette Rangel into an academic career as an independent scientist. Dr. Rangel is a behavioral scientist and post-doctoral research associate with a strong commitment to working with medically underserved cancer patients, families, and communities. Through this Diversity Supplement, she will gain crucial training in cancer control research focusing on cancer caregiving, challenges of comorbidity management during/after cancer- directed treatment, and advanced statistical analysis. With an eye toward developing interventions to support caregivers in managing patient comorbidities across the cancer control continuum, specific aims of this supplemental research are to: 1) Examine whether patient participation in the parent OPTIMISE (Oncology- Primary Care Partnership to Improve Comprehensive Survivorship Care) enhanced care pathway for comorbidity management results in improved outcomes for caregivers in terms of lower levels of caregiver burden, distress, and financial hardship relative to usual medical care (UMC); 2) Describe the challenges that caregivers face in managing patient comorbidities during cancer-directed treatment; and, 3) Describe the challenges that caregivers experience as the patient transitions from cancer-directed treatment to post-treatment survivorship. Dr. Rangel will achieve these aims by recruiting the caregivers of patients who are eligible and enrolled in the parent OPTIMISE trial and conducting a mixed-methods companion study using caregiver interview and survey data. To supplement the research plan, career development goals include 1) gaining a foundational understanding of cancer control health equity research, 2) develop theoretical and conceptual knowledge in cancer caregiving research, 3) continue developing the methodological and analytical qualitative, quantitative, and mixed methods skills required to conduct rigorous mixed methods research, and 4) acquire professional development skills to support a career as an independent investigator. Along with the valuable training and career development opportunities afforded through this supplement, the findings supported by Dr. Rangel’s research will provide crucial data on the unmet needs of cancer caregivers and enable her to develop a competitive K99/R00 proposal to develop an intervention for caregivers of cancer patients with comorbidities and launch her career as an independent investigator.